Surface contamination of antineoplastic drug vials: Comparison of unprotected and protected vials

American Journal of Health-System Pharmacy

Volumn 67, Issue 6, 2010, Pages 428-429

  Schierl, Rudolf ^a   Herwig, Autenrieth ^a   Pfaller, Andreas ^a   Groebmair, Stefan ^a   Fischer, Elke ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; IFOSFAMIDE;

DRUG CONTAMINATION; DRUG EXPOSURE; DRUG INDUSTRY; DRUG SAFETY; LETTER; MASS FRAGMENTOGRAPHY; POTENTIOMETRY; PRIORITY JOURNAL;

EID: 77949612875     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080621     Document Type: Letter

References (7)

1. Connor TH, Sessink PJ, Harrison BR et al. Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies. Am J Health-Syst Pharm. 2005;62:475-84.
2. Favier B, Gilles L, Ardiet C et al. External contamination of vials containing cytotoxic agents supplied by pharmaceutical manufacturers. J Oncol Pharm Pract. 2003;9:15-20.
3. Mason HJ, Morton J, Garfitt SJ et al. Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Ann Occup Hyg. 2003; 47:681-5.
4. Pethran A, Schierl R, Hauff K et al. Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations. Int Arch Occup Environ Health. 2003; 76:5-10.
5. Kromhout H, Hoek F, Uitterhoeve R et al. Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys. Ann Occup Hyg. 2000; 44:551-60.
6. Kittlaus W. Verpackungen zum schutz vor Zytostatika kontaminationen. Onkologische Pharmade. 2008; 10:4-10. In German.
7. Schmaus G, Schierl R, Funck S. Monitoring surface contamination by antineoplastic drugs using gas chromatography-mass spectrometry and voltammetry. Am J Health-Syst Pharm. 2002; 59:956-61.